MP26-01 BENIGN PELVIC SURGERY WITH HUGO ® RAS SYSTEM: OUR EXPERIENCE IN A TERTIARY REFERRAL ROBOTIC CENTER

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP26-01 BENIGN PELVIC SURGERY WITH HUGO® RAS SYSTEM: OUR EXPERIENCE IN A TERTIARY REFERRAL ROBOTIC CENTER Eleonora Balestrazzi, Angelo Mottaran, Carlo Andrea Bravi, Luigi Nocera, Marco Paciotti, Adele Piro, Maria Peraire Lores, Luca Sarchi, Federico Piramide, Ruben De Groote, Geert De Naeyer, and Alexandre Mottrie Eleonora BalestrazziEleonora Balestrazzi More articles by this author , Angelo MottaranAngelo Mottaran More articles by this author , Carlo Andrea BraviCarlo Andrea Bravi More articles by this author , Luigi NoceraLuigi Nocera More articles by this author , Marco PaciottiMarco Paciotti More articles by this author , Adele PiroAdele Piro More articles by this author , Maria Peraire LoresMaria Peraire Lores More articles by this author , Luca SarchiLuca Sarchi More articles by this author , Federico PiramideFederico Piramide More articles by this author , Ruben De GrooteRuben De Groote More articles by this author , Geert De NaeyerGeert De Naeyer More articles by this author , and Alexandre MottrieAlexandre Mottrie More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003254.01AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Urologic surgery for benign pelvic conditions – such as female urinary stress incontinence secondary to a pelvic organ prolapse and male benign prostatic iperplasia – can be performed using robotic and laparoscopic approaches. However, the robotic approach is still limited by platforms availability and their cost. Recently, new robotic platforms such as Hugo® Robotic Assisted Surgery (RAS) System were introduced into the market. The aim of our study was to assess the safety and technical feasibility of surgery for benign urological conditions with Hugo® RAS System. METHODS: We analysed data of 23 patients who underwent surgery for urological pelvic benign conditions at OLV Hospital (Aalst, Belgium). All surgeries were performed with HUGO™ RAS System between February and October 2022. We collected data about patient’s characteristics, operative time, intra- and post-operative complications, postoperative outcomes, clashing of instruments or technical errors of the system. RESULTS: Overall, 9 men underwent robot-assisted simple prostatectomy (RASP), 12 women robot-assisted sacropexy (RSC), 1 woman underwent robot-assisted diverticulectomy and 1 underwent robot-assisted Burch colposuspension. All procedures were completed, with no need for conversion or for placement of additional ports. No intraoperative complications and no one of the patients needed blood transfusion. One robotic monopolar curved shears had to be replaced during RASP, however no further instrument clashing or technical errors of the system occurred. Median (interquartile range [IQR]) console time for RASP was 120 (IQR: 100, 145) minutes and for RSC was 100 (IQR: 80, 100). The console time for the diverticulectomy and for the Burch colposuspension was 95 minutes and 100 minutes, respectively. Median length of stay was 4 (IQR: 3,5, 4,5) and 3 (IQR: 2, 4) days for RASP and RSC, respectively; length of stay for diverticulectomy and Burch colposuspension was 2 and 4 days, respectively. For all surgeries, vescical catheter was removed on the first operative day. Only one patient of the RASP group experienced a post-operative complication – an asymptomatic pelvic hematoma – that was conservatively treated. CONCLUSIONS: The use of HUGO® RAS system for the treatment of benign urological conditions, both in male and female patients, is safe and feasible. Awaiting further evidence on clinical outcomes, the introduction of this novel platform into the market can decrease the costs of robotic technology and thus increasing the availability of robotic surgery also for benign conditions in urology. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e352 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Eleonora Balestrazzi More articles by this author Angelo Mottaran More articles by this author Carlo Andrea Bravi More articles by this author Luigi Nocera More articles by this author Marco Paciotti More articles by this author Adele Piro More articles by this author Maria Peraire Lores More articles by this author Luca Sarchi More articles by this author Federico Piramide More articles by this author Ruben De Groote More articles by this author Geert De Naeyer More articles by this author Alexandre Mottrie More articles by this author Expand All Advertisement PDF downloadLoading ...